Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EPRX · as of Jun 8, 2026
Key Statistics
Explore Eupraxia Pharmaceuticals Inc. Data
eprx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The EPRX analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $19.00, representing +219.33% upside from the current price of $5.95.
Competitors & Peers
eprx competitorsEPRX
AARD
GNFT
IVA
MDWD
NAUTStock Performance
Full HistoryAbout Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product cand…
what is eupraxia pharmaceuticals inc. · eprx stock overview · eupraxia pharmaceuticals inc. company profile · who is eupraxia pharmaceuticals inc. ceo · eprx NASDAQ · eupraxia pharmaceuticals inc. headquarters · eupraxia pharmaceuticals inc. business segments
About Stock Overview & Key Data
Eupraxia Pharmaceuticals Inc. (EPRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 5, 2024. As of the latest trading session, EPRX stock price is $5.95, with a market capitalization of $199.2M. The stock has returned +49.87% over the past 12 months and -21.19% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Eupraxia Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $19.00. In fiscal year 2025, Eupraxia Pharmaceuticals Inc. reported revenue of — and net income of -$53.9M. For detailed data — including Eupraxia Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eupraxia Pharmaceuticals Inc. (EPRX) stock price is $5.95. The stock is traded on NASDAQ under the ticker symbol EPRX. The 52-week range is $3.85 – $9.32.